147 related articles for article (PubMed ID: 2534986)
1. Lipid abnormalities in the brain in adult Down's syndrome and Alzheimer's disease.
Brooksbank BW; Martinez M
Mol Chem Neuropathol; 1989 Dec; 11(3):157-85. PubMed ID: 2534986
[TBL] [Abstract][Full Text] [Related]
2. Gangliosides in the brain in adult Down's syndrome and Alzheimer's disease.
Brooksbank BW; McGovern J
Mol Chem Neuropathol; 1989 Dec; 11(3):143-56. PubMed ID: 2534985
[TBL] [Abstract][Full Text] [Related]
3. Altered composition of polyunsaturated fatty acyl groups in phosphoglycerides of Down's syndrome fetal brain.
Brooksbank BW; Martinez M; Balazs R
J Neurochem; 1985 Mar; 44(3):869-74. PubMed ID: 3156210
[TBL] [Abstract][Full Text] [Related]
4. Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease.
Hayn M; Kremser K; Singewald N; Cairns N; Nemethova M; Lubec B; Lubec G
Life Sci; 1996; 59(7):537-44. PubMed ID: 8761342
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease.
Mann DM; Jones D; Prinja D; Purkiss MS
Acta Neuropathol; 1990; 80(3):318-27. PubMed ID: 1698007
[TBL] [Abstract][Full Text] [Related]
6. Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content.
Corrigan FM; Horrobin DF; Skinner ER; Besson JA; Cooper MB
Int J Biochem Cell Biol; 1998 Feb; 30(2):197-207. PubMed ID: 9608673
[TBL] [Abstract][Full Text] [Related]
7. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain.
Kida E; Choi-Miura NH; Wisniewski KE
Brain Res; 1995 Jul; 685(1-2):211-6. PubMed ID: 7583250
[TBL] [Abstract][Full Text] [Related]
8. Increased protein levels of serotonin transporter in frontal cortex of patients with Down syndrome.
Gulesserian T; Engidawork E; Cairns N; Lubec G
Neurosci Lett; 2000 Dec; 296(1):53-7. PubMed ID: 11099832
[TBL] [Abstract][Full Text] [Related]
9. Altered composition of cerebral microvessel membrane phosphoglycerides from senescent mouse.
Williams WM; Rapoport SI
J Neurochem; 1993 Nov; 61(5):1843-9. PubMed ID: 8228998
[TBL] [Abstract][Full Text] [Related]
10. The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndrome.
Seo H; Isacson O
J Neurochem; 2010 Sep; 114(6):1819-26. PubMed ID: 20698932
[TBL] [Abstract][Full Text] [Related]
11. Phospholipid composition and levels are altered in Down syndrome brain.
Murphy EJ; Schapiro MB; Rapoport SI; Shetty HU
Brain Res; 2000 Jun; 867(1-2):9-18. PubMed ID: 10837793
[TBL] [Abstract][Full Text] [Related]
12. Dolichols are elevated in brain tissue from Alzheimer's disease, but not in urinary sediment from Alzheimer's disease and Down's syndrome.
Wolfe LS; Ng Ying Kin NM; Palo J; Bergeron C; Kotila M; Varonen S
Neurochem Pathol; 1985; 3(4):213-21. PubMed ID: 2938031
[TBL] [Abstract][Full Text] [Related]
13. Heat-shock protein 70 levels in brain of patients with Down syndrome and Alzheimer's disease.
Yoo BC; Seidl R; Cairns N; Lubec G
J Neural Transm Suppl; 1999; 57():315-22. PubMed ID: 10666686
[TBL] [Abstract][Full Text] [Related]
14. Dietary DHA supplementation causes selective changes in phospholipids from different brain regions in both wild type mice and the Tg2576 mouse model of Alzheimer's disease.
Bascoul-Colombo C; Guschina IA; Maskrey BH; Good M; O'Donnell VB; Harwood JL
Biochim Biophys Acta; 2016 Jun; 1861(6):524-37. PubMed ID: 26968097
[TBL] [Abstract][Full Text] [Related]
15. Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease.
Lumbreras M; Baamonde C; Martínez-Cué C; Lubec G; Cairns N; Sallés J; Dierssen M; Flórez J
Amino Acids; 2006 Nov; 31(4):449-56. PubMed ID: 16583316
[TBL] [Abstract][Full Text] [Related]
16. Expression of DNA excision-repair-cross-complementing proteins p80 and p89 in brain of patients with Down Syndrome and Alzheimer's disease.
Hermon M; Cairns N; Egly JM; Fery A; Labudova O; Lubec G
Neurosci Lett; 1998 Jul; 251(1):45-8. PubMed ID: 9714461
[TBL] [Abstract][Full Text] [Related]
17. Neuronal maturation in the foetal brain in Down's syndrome.
Brooksbank BW; Walker D; Balázs R; Jørgensen OS
Early Hum Dev; 1989 Feb; 18(4):237-46. PubMed ID: 2522874
[TBL] [Abstract][Full Text] [Related]
18. Chronic dietary n-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum, and cerebellum.
Favrelière S; Barrier L; Durand G; Chalon S; Tallineau C
Lipids; 1998 Apr; 33(4):401-7. PubMed ID: 9590628
[TBL] [Abstract][Full Text] [Related]
19. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
[TBL] [Abstract][Full Text] [Related]
20. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease.
Yates CM; Simpson J; Gordon A
Neurosci Lett; 1986 Apr; 65(2):189-92. PubMed ID: 2940479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
